Anne Ibach
Internal Medicine · Raleigh, NCNPI 1023012309
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,057 and has fallen 77.0% since, to $243 in 2022.
Across 122 payments — averaging $14.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$245
- Sunovion Pharmaceuticals Inc.$184
- Johnson & Johnson$152
- GSK$149
- Pfizer$125
- Novartis$117
- plus $781 from 22 others
What the payments were for
- Food & beverage$1,753100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 17 | $245 |
| Sunovion Pharmaceuticals Inc. | 14 | $184 |
| Johnson & Johnson | 12 | $152 |
| GSK | 11 | $149 |
| Pfizer | 9 | $125 |
| Novartis | 8 | $117 |
| AstraZeneca | 8 | $113 |
| Amgen(2 entities) | 5 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $67 |
| Astellas Pharma US Inc | 3 | $54 |
| Merck | 4 | $51 |
| Insulet Corporation | 1 | $47 |
| Eisai Inc. | 2 | $43 |
| Lilly USA, LLC | 3 | $42 |
| Arbor Pharmaceuticals, Inc. | 3 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| AbbVie | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $29 |
| Mylan Specialty L.p. | 2 | $26 |
| Corcept Therapeutics | 1 | $20 |
| Bayer | 1 | $19 |
| Boehringer Ingelheim | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Medtronic | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
How this compares
$1,753 in reported general payments places this provider in the 80th percentile of 3,302 internal medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dutasteride | 11 | $140 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Raleigh
- Bhakti PaulRaleigh$536K
- Christina CraterRaleigh$330K
- Charles CookRaleigh$228K
- Anthony AzziRaleigh$81K
- Dishita PandyaRaleigh$71K
- Afreen ShariffRaleigh$66K
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Mary KlotmanDurham$478K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.